What are the best dietary strategies for luteal phase defect and low progesterone?
In clinical medicine, luteal phase defect and low progesterone is primarily driven by targeted biochemical, hormonal, or cellular signaling alterations. Contemporary peer-reviewed evidence indicates that comprehensive quantitative biomarker testing combined with multi-targeted clinical therapies (including pharmacotherapy and physiological lifestyle interventions) yields favorable clinical recovery rates. It is recommended to evaluate complete laboratory panels before initiating targeted intervention.